{{Drugbox
| IUPAC_name               = 3-[(3,4-Dihydroxy-5-nitrophenyl)methylidene]pentane-2,4-dione
| image                    = Nitecapone.svg
| alt                      = Skeletal formula
| width                    = 200
| image2                   = Nitecapone molecule spacefill.png
| alt2                     = Space-filling model
| CAS_number               = 116313-94-1
| CAS_supplemental         = 
| ATC_prefix               = None
| ATC_suffix               = 
| PubChem                  = 5464105
| ChemSpiderID             = 4576539
| KEGG                     = D03241
| UNII                     = 98BS722498
| ChEMBL                   = 167055
| C=12 | H=11 | N=1 | O=6
| molecular_weight         = 265.219 g/mol
| smiles                   = [O-][N+](=O)c1cc(\C=C(/C(=O)C)C(=O)C)cc(O)c1O
| StdInChI                 = 1S/C12H11NO6/c1-6(14)9(7(2)15)3-8-4-10(13(18)19)12(17)11(16)5-8/h3-5,16-17H,1-2H3
| StdInChIKey              = UPMRZALMHVUCIN-UHFFFAOYSA-N
| bioavailability          = 
| protein_bound            = 
| metabolism               = 
| elimination_half-life    = 
| excretion                = 
| pregnancy_category       = 
| legal_status             = 
| routes_of_administration = 
}}

'''Nitecapone''' ([[International Nonproprietary Name|INN]]; '''OR-462''') is a [[drug]] which acts as a [[binding selectivity|selective]] [[enzyme inhibitor|inhibitor]] of the [[enzyme]] [[catechol-O-methyl transferase|catechol ''O''-methyl transferase]] (COMT).<ref name="Macdonald1997">{{cite book | author = F.. Macdonald | title = Dictionary of Pharmacological Agents | url = https://books.google.com/books?id=A0THacd46ZsC&pg=PA1435 | accessdate = 20 May 2012 | year = 1997 | publisher = CRC Press | isbn = 978-0-412-46630-4 | page = 1635}}</ref><ref name="pmid3181288">{{cite journal |vauthors=Nissinen E, Lindén IB, Schultz E, Kaakkola S, Männistö PT, Pohto P | title = Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat | journal = European Journal of Pharmacology | volume = 153 | issue = 2-3 | pages = 263–9 |date=August 1988 | pmid = 3181288 | doi = 10.1016/0014-2999(88)90614-0| url = }}</ref> It was patented as an [[antiparkinsonian agent]] but was never marketed.<ref name="Macdonald1997" />

== See also ==
* [[COMT inhibitor]]

== References ==
{{Reflist}}

{{Antiparkinson}}
{{Monoamine metabolism modulators}}

[[Category:Catechols]]
[[Category:COMT inhibitors]]
[[Category:Diketones]]
[[Category:Nitrobenzenes]]


{{nervous-system-drug-stub}}